Internal Reference Number: FOI_7539
Date Request Received: 09/11/2023 00:00:00
Date Request Replied To: 24/11/2023 00:00:00
This response was sent via: By Email
Request Summary: Treatment for Myelofibrosis
Request Category: Companies
Question Number 1: Please provide the total number of patients treated in the last 6 months for: • Polycythaemia Vera (ICD10 code D45) • Myelofibrosis (ICD10 code D47.4) • Myelofibrosis (ICD10 code D47.4) patients aged 65 and older | |
Answer To Question 1: Polycythaemia Vera (ICD10 code D45) 47 patients Myelofibrosis (ICD10 code D47.4) 13 patients Myelofibrosis (ICD10 code D47.4) patients aged 65 and older 9 patients | |
Question Number 2: How many patients were treated in the past 6 months (for any disease) with: • Ruxolitinib • Fedratinib • Interferon (any type) | |
Answer To Question 2: Ruxolitinib 11 patients Fedratinib <5 patients Interferon (any type) 6 patients | |
Question Number 3: Of the patients treated in the past 6 months with Ruxolitinib, how many patients had a diagnosis for: • Polycythaemia Vera (ICD10 code D45) • Myelofibrosis (ICD10 code D47.4) | |
Answer To Question 3: Polycythaemia Vera (ICD10 code D45) - > 5 patients Myelofibrosis (ICD10 code D47.4) 10 patients | |
Question Number 4: How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years? • Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? • Of these patients, how many were treated in the past 6 months with Interferon therapy? • Of these patients, how many have received no active treatment in the past 6 months? | |
Answer To Question 4: Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? < 5 patients Of these patients, how many were treated in the past 6 months with Interferon therapy? < 5 patients Of these patients, how many have received no active treatment in the past 6 months? 8 patients | |
Question Number 5: How many Polycythaemia Vera (ICD10 code D45) patients has your trust diagnosed in the past 3 years? • Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? • Of these patients, how many were treated in the past 6 months with Interferon therapy? | |
Answer To Question 5: Of these patients, how many were treated in the past 6 months with Hydroxycarbamide? < 5 patients Of these patients, how many were treated in the past 6 months with Interferon therapy? < 5 patients | |
Question Number 6: Does your trust participate in any clinical trials for the treatment of myelofibrosis? If so, can you please provide the name of each trial along with the number of patients taking part. | |
Answer To Question 6: none | |
To return to the list of all the FOI requests please click here |
Our staff at 91Ó°ÊÓ District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.